on 09 Feb 2021
Last Applicant/ Owned by
19 Newport Road, Cardiff South Glamorg
Serial Number
79280356 filed on 14th Nov 2019
Registration Number
6263411 registered on 09th Feb 2021
Correspondent Address
Manuel Valcarcel
Filing Basis
No Filing Basis
Disclaimer
"PHARMA"
Pharmaceutical preparations and medicines containing nano-particles for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorderRead More
Active chemical ingredients for use in the manufacture of pharmaceuticals, cosmetics and medicines for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; nano-particle ingredients for use in pharmaceuticals, medicines and medicated cosmetics for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders
Pharmaceutical preparations and medicines containing nano-particles for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; vaccines incorporating nano-particles
Custom manufacture of nano-particles for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders; custom manufacture of pharmaceuticals and medicines containing nano-particles; custom manufacture of nano-particle devices for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system and central nervous system related diseases and disorders
Scientific research services for others in the field of nano-particle technology; pharmaceutical and drug development and drug discovery services; scientific laboratory services, namely, testing, efficiency evaluation and advisory services in the field of nano-particles and nano-medicine; scientific laboratory services, namely, testing, efficiency and technical and scientific advisory services in the field of pharmaceuticals; scientific research laboratory services, namely, nano-particle laboratory services
No 79280356
No Service Mark
No 061266.01010
No
No
No
No
No
No
No
No
26.01.09 -
Geometric figures, objects, humans, plants or animals forming or bordering the perimeter of a circle
26.01.21 -
Circles that are totally or partially shaded
26.01.31 -
Five or more circles
The mark consists of the wording "MIDATECH" in dark blue above the wording "PHARMA" in light blue. Next to the wording starts an incomplete circular array of light and blue dots that bend towards the letter "E" in "MIDATECH". White appearing in the mark is background and not claimed as a feature of the mark.
Status Date | Action Taken |
---|---|
07th Jun 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
12th May 2021 | FINAL DISPOSITION PROCESSED |
12th May 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
09th May 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
09th Feb 2021 | REGISTERED-PRINCIPAL REGISTER |
06th Dec 2020 | NOTIFICATION PROCESSED BY IB |
24th Nov 2020 | PUBLISHED FOR OPPOSITION |
24th Nov 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
18th Nov 2020 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
18th Nov 2020 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |